News Boehringer files for new rare disease use for nintedanib in EU, US Richard Staines Boehringer Ingelheim, IPF, nintedanib, SSc-ILD, systemic sclerosis 0 Comment Boehringer Ingelheim has filed for a new use for its lung drug nintedanib in the US and Europe, Share X Boehringer files for new rare disease use for nintedanib in EU, US https://pharmaphorum.com/news/boehringer-files-for-new-rare-disease-use-for-nintedanib-in-eu-us/